Abstract
This paper discusses the risk of gross negligence manslaughter (GNM) and corporate manslaughter charges (CM) when clinicians use an artificially intelligent system’s (AIS’s) outputs in their practice. I identify the elements of these offenses within the context of the law of England and Wales and explore how they could be applied in a potential scenario where a patient's death has followed AIS use by a clinician. The risk of a conviction due to making an AIS-augmented workplace mistake highlights the non-trivial nature of AIS adoption in healthcare, and that the consequences of its use must be considered by all interested parties prior to AIS adoption.
Original language | English |
---|---|
Number of pages | 15 |
Journal | The New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body |
Early online date | 22 Oct 2024 |
DOIs | |
Publication status | E-pub ahead of print - 22 Oct 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.